Search by Drug Name or NDC
NDC 72572-0127-10 DEXMEDETOMIDINE HYDROCHLORIDE 4 ug/mL Details
DEXMEDETOMIDINE HYDROCHLORIDE 4 ug/mL
DEXMEDETOMIDINE HYDROCHLORIDE is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by CIVICA, INC.. The primary component is DEXMEDETOMIDINE HYDROCHLORIDE.
Product Information
| NDC | 72572-0127 |
|---|---|
| Product ID | 72572-127_fb0759f3-818c-4e6e-9aa7-ac94f7d59de8 |
| Associated GPIs | 60206030202020 |
| GCN Sequence Number | 070876 |
| GCN Sequence Number Description | dexmedetomidine in 0.9 % NaCl INFUS. BTL 200 MCG/50 INTRAVEN |
| HIC3 | H2E |
| HIC3 Description | SEDATIVE-HYPNOTICS,NON-BARBITURATE |
| GCN | 34538 |
| HICL Sequence Number | 040230 |
| HICL Sequence Number Description | DEXMEDETOMIDINE HCL IN 0.9 % SODIUM CHLORIDE |
| Brand/Generic | Generic |
| Proprietary Name | DEXMEDETOMIDINE HYDROCHLORIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | dexmedetomidine hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 4 |
| Active Ingredient Units | ug/mL |
| Substance Name | DEXMEDETOMIDINE HYDROCHLORIDE |
| Labeler Name | CIVICA, INC. |
| Pharmaceutical Class | Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA212791 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 72572-0127-10 (72572012710)
| NDC Package Code | 72572-127-10 |
|---|---|
| Billing NDC | 72572012710 |
| Package | 10 BOTTLE in 1 CARTON (72572-127-10) / 50 mL in 1 BOTTLE (72572-127-01) |
| Marketing Start Date | 2021-08-23 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |